Lataa...
Cancer Immunotherapy: Sipuleucel-T and Beyond
In April 2010, sipuleucel-T became the first anticancer vaccine approved by the United States Food and Drug Administration. Different from the traditional chemotherapy agents that produce widespread cytotoxicity to kill tumor cells, anticancer vaccines and immunotherapies focus on empowering the imm...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4159742/ https://ncbi.nlm.nih.gov/pubmed/21923608 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1592/phco.31.8.813 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|